Moreover, inhibition of NIK with a highly selective small-molecule inhibitor alleviated autoimmune symptoms in a mouse model of SLE, as shown by improved survival, reduced renal pathology, and decreased proteinuria scores [228]. The gene discussed is MAP3K14; the disease is systemic lupus erythematosus.